Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Fux, CA"" wg kryterium: Autor


Tytuł:
Association of antimicrobial perioperative prophylaxis with cefuroxime plus metronidazole or amoxicillin/clavulanic acid and surgical site infections in colorectal surgery.
Autorzy:
Stavropoulou E; Service of Infectious Diseases, Central Institute, Valais Hospital, Sion, Switzerland.; Service of Infectious Diseases, Department of Medicine, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
Atkinson A; Department of Infectious Diseases, Bern University Hospital, Inselspital, University of Bern, Bern, Switzerland.; Division of Infectious Diseases, Washington University School of Medicine, St. Louis, MO, USA.
Eisenring MC; Service of Infectious Diseases, Central Institute, Valais Hospital, Sion, Switzerland.; Swissnoso, National Center for Infection Prevention, Bern, Switzerland.
Fux CA; Division of Infectious Diseases and Infection Prevention, Kantonsspital Aarau, Aarau, Switzerland.
Marschall J; Department of Infectious Diseases, Bern University Hospital, Inselspital, University of Bern, Bern, Switzerland.; Division of Infectious Diseases, Washington University School of Medicine, St. Louis, MO, USA.
Senn L; Swissnoso, National Center for Infection Prevention, Bern, Switzerland. .; Infection Prevention and Control Unit, Service of Infectious Diseases, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. .
Troillet N; Service of Infectious Diseases, Central Institute, Valais Hospital, Sion, Switzerland.; Swissnoso, National Center for Infection Prevention, Bern, Switzerland.
Pokaż więcej
Źródło:
Antimicrobial resistance and infection control [Antimicrob Resist Infect Control] 2023 Sep 19; Vol. 12 (1), pp. 105. Date of Electronic Publication: 2023 Sep 19.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Colorectal Surgery*/adverse effects
Anti-Infective Agents*
Gammaproteobacteria*
Humans ; Female ; Male ; Metronidazole/therapeutic use ; Surgical Wound Infection/prevention & control ; Cefuroxime/therapeutic use ; Amoxicillin-Potassium Clavulanate Combination/therapeutic use
Czasopismo naukowe
Tytuł:
Association of endothelial activation assessed through endothelin-I precursor peptide measurement with mortality in COVID-19 patients: an observational analysis.
Autorzy:
Gregoriano C; Medical University Department of Medicine, Kantonsspital Aarau, Tellstrasse, CH-5001, Aarau, Switzerland. .
Damm D; Medical University Department of Medicine, Kantonsspital Aarau, Tellstrasse, CH-5001, Aarau, Switzerland.
Kutz A; Medical University Department of Medicine, Kantonsspital Aarau, Tellstrasse, CH-5001, Aarau, Switzerland.
Koch D; Medical University Department of Medicine, Kantonsspital Aarau, Tellstrasse, CH-5001, Aarau, Switzerland.
Wolfisberg S; Medical University Department of Medicine, Kantonsspital Aarau, Tellstrasse, CH-5001, Aarau, Switzerland.
Haubitz S; Medical University Department of Medicine, Kantonsspital Aarau, Tellstrasse, CH-5001, Aarau, Switzerland.; Department of Infectious Diseases and Hospital Hygiene, Kantonsspital Aarau, Switzerland.
Conen A; University of Basel, Basel, Switzerland.; Department of Infectious Diseases and Hospital Hygiene, Kantonsspital Aarau, Switzerland.
Bernasconi L; Institute of Laboratory Medicine, Kantonsspital Aarau, Aarau, Switzerland.
Hammerer-Lercher A; Institute of Laboratory Medicine, Kantonsspital Aarau, Aarau, Switzerland.
Fux CA; Medical University Department of Medicine, Kantonsspital Aarau, Tellstrasse, CH-5001, Aarau, Switzerland.; Department of Infectious Diseases and Hospital Hygiene, Kantonsspital Aarau, Switzerland.
Mueller B; Medical University Department of Medicine, Kantonsspital Aarau, Tellstrasse, CH-5001, Aarau, Switzerland.; University of Basel, Basel, Switzerland.
Schuetz P; Medical University Department of Medicine, Kantonsspital Aarau, Tellstrasse, CH-5001, Aarau, Switzerland.; University of Basel, Basel, Switzerland.
Pokaż więcej
Źródło:
Respiratory research [Respir Res] 2021 May 13; Vol. 22 (1), pp. 148. Date of Electronic Publication: 2021 May 13.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19/*mortality
COVID-19/*physiopathology
Endothelin-1/*analysis
Endothelium, Vascular/*physiopathology
Protein Precursors/*analysis
Age Factors ; Aged ; Aged, 80 and over ; Biomarkers/analysis ; Blood Pressure ; Cohort Studies ; Creatinine/blood ; Endpoint Determination ; Female ; Humans ; Male ; Middle Aged ; Prognosis ; Prospective Studies ; Reproducibility of Results ; Risk Factors ; Sex Factors ; Survival Analysis
Czasopismo naukowe
Tytuł:
Risk of SARS-CoV-2 transmission by aerosols, the rational use of masks, and protection of healthcare workers from COVID-19.
Autorzy:
Sommerstein R; Department of Infectious, Diseases and Hospital Hygiene, Freiburgstrasse, 3010, Bern, Switzerland. .; Swissnoso, the National Center for Infection Control, Bern, Switzerland. .
Fux CA; Department of Infectious Diseases and Hospital Hygiene, Aarau Cantonal Hospital, Aarau, Switzerland.
Vuichard-Gysin D; Swissnoso, the National Center for Infection Control, Bern, Switzerland.; Department of Infectious Diseases, Thurgau Cantonal Hospital, Thurgau, Switzerland.
Abbas M; Infection Control Programme and Division of Infectious Diseases, University of Geneva Hospitals and Faculty of Medicine, Geneva, Switzerland.
Marschall J; Department of Infectious, Diseases and Hospital Hygiene, Freiburgstrasse, 3010, Bern, Switzerland.; Swissnoso, the National Center for Infection Control, Bern, Switzerland.
Balmelli C; Swissnoso, the National Center for Infection Control, Bern, Switzerland.; Infection Control Programme, EOC Hospitals, Ticino, Switzerland.
Troillet N; Swissnoso, the National Center for Infection Control, Bern, Switzerland.; Service of Infectious Diseases, Central Institute, Valais Hospitals, Sion, Switzerland.
Harbarth S; Swissnoso, the National Center for Infection Control, Bern, Switzerland.; Infection Control Programme and Division of Infectious Diseases, University of Geneva Hospitals and Faculty of Medicine, Geneva, Switzerland.
Schlegel M; Swissnoso, the National Center for Infection Control, Bern, Switzerland.; Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.
Widmer A; Swissnoso, the National Center for Infection Control, Bern, Switzerland.; Department of Infectious Diseases, University Hospital Basel, Basel, Switzerland.
Pokaż więcej
Corporate Authors:
Swissnoso
Źródło:
Antimicrobial resistance and infection control [Antimicrob Resist Infect Control] 2020 Jul 06; Vol. 9 (1), pp. 100. Date of Electronic Publication: 2020 Jul 06.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Aerosols/*analysis
Betacoronavirus/*physiology
Coronavirus Infections/*prevention & control
Coronavirus Infections/*transmission
Pandemics/*prevention & control
Pneumonia, Viral/*prevention & control
Pneumonia, Viral/*transmission
Air Microbiology ; COVID-19 ; Coronavirus Infections/virology ; Health Personnel ; Humans ; Infectious Disease Transmission, Patient-to-Professional/prevention & control ; Pneumonia, Viral/virology ; Protective Devices ; SARS-CoV-2
Czasopismo naukowe
Tytuł:
Rates and predictors of switching to tenofovir alafenamide-containing ART in a nationwide cohort.
Autorzy:
Surial B; Department of Infectious Diseases, Bern University Hospital, University of Bern, Bern, Switzerland.
Cavassini M; Division of Infectious Diseases, University Hospital of Lausanne, University of Lausanne, Lausanne, Switzerland.
Calmy A; Division of Infectious Diseases, Geneva University Hospital, University of Geneva, Geneva, Switzerland.
Fehr J; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.; Department of Public Health, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.
Stöckle M; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, University of Basel, Basel, Switzerland.
Bernasconi E; Division of Infectious Diseases, Regional Hospital of Lugano, Lugano, Switzerland.
Roth B; Division of Infectious Diseases, Cantonal Hospital of St Gallen, St Gallen, Switzerland.
Fux CA; Division of Infectious Diseases, Cantonal Hospital of Aarau, Aarau, Switzerland.
Kovari H; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Furrer H; Department of Infectious Diseases, Bern University Hospital, University of Bern, Bern, Switzerland.
Rauch A; Department of Infectious Diseases, Bern University Hospital, University of Bern, Bern, Switzerland.
Wandeler G; Department of Infectious Diseases, Bern University Hospital, University of Bern, Bern, Switzerland. .; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland. .
Pokaż więcej
Corporate Authors:
Swiss HIV Cohort Study
Źródło:
BMC infectious diseases [BMC Infect Dis] 2019 Oct 10; Vol. 19 (1), pp. 834. Date of Electronic Publication: 2019 Oct 10.
Typ publikacji:
Journal Article
MeSH Terms:
Adenine/*analogs & derivatives
Anti-HIV Agents/*therapeutic use
HIV Infections/*drug therapy
Adenine/therapeutic use ; Adult ; Alanine ; CD4 Lymphocyte Count ; Cohort Studies ; Drug Interactions ; Female ; HIV Infections/complications ; Hepatitis C, Chronic/complications ; Hepatitis C, Chronic/pathology ; Humans ; Male ; Middle Aged ; Risk Factors ; Switzerland ; Tenofovir/adverse effects ; Tenofovir/therapeutic use
Czasopismo naukowe
Tytuł:
Mortality from suicide among people living with HIV and the general Swiss population: 1988-2017.
Autorzy:
Ruffieux Y; Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.
Lemsalu L; Department of Drug and Infectious Diseases Epidemiology, National Institute for Health Development, Tallinn, Estonia.; Institute of Family Medicine and Public Health, University of Tartu, Tartu, Estonia.
Aebi-Popp K; Division of Infectious Diseases, Bern University Hospital, University of Bern, Bern, Switzerland.
Calmy A; Division of Infectious Diseases, University Hospital Geneva, University of Geneva, Geneva, Switzerland.
Cavassini M; Division of Infectious Diseases, University Hospital Lausanne, University of Lausanne, Lausanne, Switzerland.
Fux CA; Department of Infectious Diseases and Hospital Hygiene, Kantonsspital Aarau, Aarau, Switzerland.
Günthard HF; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
Marzolini C; Division of Infectious Diseases and Hospital Epidemiology, Departments of Medicine and Clinical Research, University Hospital Basel, Basel, Switzerland.; University of Basel, Basel, Switzerland.
Scherrer A; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
Vernazza P; Department of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St Gallen, St Gallen, Switzerland.
Keiser O; Institute of Global Health, University of Geneva, Geneva, Switzerland.
Egger M; Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.; Centre of Infectious Disease Epidemiology and Research (CIDER), University of Cape Town, Cape Town, South Africa.
Pokaż więcej
Corporate Authors:
Swiss HIV Cohort Study and the Swiss National Cohort
Źródło:
Journal of the International AIDS Society [J Int AIDS Soc] 2019 Aug; Vol. 22 (8), pp. e25339.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Suicide*/statistics & numerical data
HIV Infections/*mortality
Adult ; Anti-Retroviral Agents/therapeutic use ; Antiretroviral Therapy, Highly Active/methods ; Cohort Studies ; Female ; HIV Infections/drug therapy ; Humans ; Male ; Middle Aged ; Risk Factors ; Switzerland/epidemiology
Czasopismo naukowe
Tytuł:
Validation of a Prediction Rule for Legionella Pneumonia in Emergency Department Patients.
Autorzy:
Bolliger R; Department of General Internal and Emergency Medicine, University Department of Medicine, Kantonsspital Aarau, Aarau, Switzerland.; Faculty of Medicine, University of Basel, Basel, Switzerland.
Neeser O; Department of General Internal and Emergency Medicine, University Department of Medicine, Kantonsspital Aarau, Aarau, Switzerland.; Faculty of Medicine, University of Basel, Basel, Switzerland.
Merker M; Department of General Internal and Emergency Medicine, University Department of Medicine, Kantonsspital Aarau, Aarau, Switzerland.; Faculty of Medicine, University of Basel, Basel, Switzerland.
Vukajlovic T; Faculty of Medicine, University of Basel, Basel, Switzerland.
Felder L; Faculty of Medicine, University of Basel, Basel, Switzerland.
Fiumefreddo R; Department of General Internal and Emergency Medicine, University Department of Medicine, Kantonsspital Aarau, Aarau, Switzerland.
Haubitz S; Department of General Internal and Emergency Medicine, University Department of Medicine, Kantonsspital Aarau, Aarau, Switzerland.; Department of Infectious Diseases, University Department of Medicine, Kantonsspital Aarau, Aarau, Switzerland.
Koch D; Department of General Internal and Emergency Medicine, University Department of Medicine, Kantonsspital Aarau, Aarau, Switzerland.
Hammerer-Lercher A; Department of Laboratory Medicine, Kantonsspital Aarau, Aarau, Switzerland.
Ottiger C; Department of Laboratory Medicine, Kantonsspital Aarau, Aarau, Switzerland.
Fux CA; Department of General Internal and Emergency Medicine, University Department of Medicine, Kantonsspital Aarau, Aarau, Switzerland.; Department of Infectious Diseases, University Department of Medicine, Kantonsspital Aarau, Aarau, Switzerland.
Mueller B; Department of General Internal and Emergency Medicine, University Department of Medicine, Kantonsspital Aarau, Aarau, Switzerland.; Faculty of Medicine, University of Basel, Basel, Switzerland.
Schuetz P; Department of General Internal and Emergency Medicine, University Department of Medicine, Kantonsspital Aarau, Aarau, Switzerland.; Faculty of Medicine, University of Basel, Basel, Switzerland.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2019 Jun 04; Vol. 6 (7), pp. ofz268. Date of Electronic Publication: 2019 Jun 04 (Print Publication: 2019).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Reasons for late presentation to HIV care in Switzerland.
Autorzy:
Hachfeld A; Department of Infectious Diseases, Bern University Hospital, University of Bern, Bern, Switzerland.
Ledergerber B; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Darling K; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Lausanne, Lausanne, Switzerland.
Weber R; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Calmy A; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Geneva, Geneva, Switzerland.
Battegay M; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, University of Basel, Basel, Switzerland.
Sugimoto K; Cantonal Hospital, St. Gallen, Switzerland.
Di Benedetto C; Regional Hospital, Lugano, Switzerland.
Fux CA; Cantonal Hospital Aargau, Aargau, Switzerland.
Tarr PE; Cantonal Hospital Baselland, Bruderholz, University of Basel, Basel, Switzerland.
Kouyos R; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Furrer H; Department of Infectious Diseases, Bern University Hospital, University of Bern, Bern, Switzerland; .
Wandeler G; Department of Infectious Diseases, Bern University Hospital, University of Bern, Bern, Switzerland.; Institute of Social and Preventive Medicine, University of Bern, Switzerland; .
Pokaż więcej
Corporate Authors:
Swiss HIV Cohort Study
Źródło:
Journal of the International AIDS Society [J Int AIDS Soc] 2015 Nov 18; Vol. 18, pp. 20317. Date of Electronic Publication: 2015 Nov 18 (Print Publication: 2015).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
HIV Infections/*diagnosis
Adult ; CD4 Lymphocyte Count ; Cohort Studies ; Female ; HIV Infections/immunology ; HIV Infections/psychology ; Humans ; Male ; Middle Aged ; Prospective Studies ; Risk Factors ; Switzerland
Czasopismo naukowe
Tytuł:
Strong Impact of Smoking on Multimorbidity and Cardiovascular Risk Among Human Immunodeficiency Virus-Infected Individuals in Comparison With the General Population.
Autorzy:
Hasse B; Division of Infectious Diseases and Hospital Epidemiology , University of Zurich, University Hospital Zurich.
Tarr PE; Division of Infectious Diseases and Hospital Epidemiology , Kantonsspital Baselland Bruderholz, University of Basel , Bruderholz.
Marques-Vidal P; Departments of Medicine, Internal Medicine.
Waeber G; Departments of Medicine, Internal Medicine.
Preisig M; Psychiatry.
Mooser V; Pathology and Laboratory Medicine , Lausanne University Hospital (Centre Hospitalier Universitaire Vaudois).
Valeri F; Institute of Primary Care, University of Zurich, University Hospital Zurich.
Djalali S; Institute of Primary Care, University of Zurich, University Hospital Zurich.
Andri R; Division of Infectious Diseases and Hospital Epidemiology , University and Inselspital Berne.
Bernasconi E; Division of Infectious Diseases , Regional Hospital , Lugano.
Calmy A; Division of Infectious Diseases , University Hospital Geneva.
Cavassini M; Division of Infectious Diseases , Centre Hospitalier Universitaire Vaudois and University of Lausanne.
Vernazza P; Division of Infectious Diseases and Hospital Epidemiology , Cantonal Hospital , St. Gallen.
Battegay M; Division of Infectious Diseases and Hospital Epidemiology , University Hospital Basel , Switzerland.
Weber R; Division of Infectious Diseases and Hospital Epidemiology , University of Zurich, University Hospital Zurich.
Senn O; Institute of Primary Care, University of Zurich, University Hospital Zurich.
Vollenweider P; Departments of Medicine, Internal Medicine.
Ledergerber B; Division of Infectious Diseases and Hospital Epidemiology , University of Zurich, University Hospital Zurich.
Aubert V
Barth J
Battegay M
Bernasconi E
Böni J
Bucher HC
Burton-Jeangros C
Calmy A
Cavassini M
Egger M
Elzi L
Fehr J
Fellay J
Furrer H
Fux CA
Gorgievski M
Günthard H
Haerry D
Hasse B
Hirsch HH
Hösli I
Kahlert C
Kaiser L
Keiser O
Klimkait T
Kouyos R
Kovari H
Ledergerber B
Martinetti G
Martinez de Tejada B
Metzner K
Müller N
Nadal D
Pantaleo G
Rauch A
Regenass S
Rickenbach M
Rudin C
Schöni-Affolter F
Schmid P
Schultze D
Schüpbach J
Speck R
Staehelin C
Tarr P
Telenti A
Trkola A
Vernazza P
Weber R
Yerly S
Jean-Michel A
Murielle B
Jean Michel G
Christoph H
Thomas L
Pedro MV
Vincent M
Fred P
Martin P
Peter V
Roland VK
Aidacic V
Gerard W
Jürg B
Markus B
Heinz B
Martin B
Hans-Ulrich B
Ivo B
Reto C
Isabelle C
Corinne C
Sima D
Peter D
Simone E
Andrea F
Markus F
Claudius F
Jakob F
Ali GM
Matthias G
Denis H
Marcel H
Walter H
Simon H
Felix H
Paul H
Eva K
Vladimir K
Daniel K
Stephan K
Beat K
Benedict K
Heidi K
Vesna L
Giovanni L
Werner LH
Phillippe L
Severin L
Christoph M
Jürgen M
Damian M
Werner M
Titus M
Valentina N
Jakob R
Thomas R
Hana S
Frank S
Georg S
Oliver S
Pietro S
Jacques S
Alfred S
Alois S
Claudia S
Othmar S
Phuoc TT
Marco V
Alessandro V
René VA
Hans W
Fritz W
Johanna WS
Joseph W
Marco Z
Pokaż więcej
Corporate Authors:
CoLaus Cohort, FIRE and the Swiss HIV Cohort Study
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2015 Jul 08; Vol. 2 (3), pp. ofv108. Date of Electronic Publication: 2015 Jul 08 (Print Publication: 2015).
Typ publikacji:
Journal Article
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies